Vascular Strategry provides in vitro, cell based and small animal in vivo models for drug efficacy endpoints. Cell-based cholesterol efflux studies, reverse cholesterol transport assays, in vitro and in vivo immune marker assessment for therapeutic areas including Cardiovascular, Metabolic and Diabetes, CNS, and immunology. Lipoprotein profiling and kinetics, Immune modulators, cytokine analysis, in vivo studies.